Patents/Assignees

Iterion Therapeutics, Inc.

8 patents in portfolio

US12491162utility2025
Formulations of Tegavivint
0 cites
US12297185utility2025
Crystalline Form of Tegavivint, Method of Preparation, and Use Thereof
0 cites
US12246010utility2025
Formulations of Tegavivint and Related Compounds
0 cites
US12208166utility2025
Lyophilized Formulations of Tegavivint
0 cites
US11964054utility2024
Formulations of Tegavivint
0 cites
US11793759utility2023
Lyophilized Formulations of Tegavivint
0 cites
US11602501utility2023
Lyophilized Formulations of Tegavivint
0 cites
US11571388utility2023
Lyophilized Formulations of Tegavivint
0 cites